Notably, multiple linear regression analysis revealed that low pretreatment CDK12/13 expression (Supplemental Figure 2, left) or high pretreatment STING activity signature expression (Supplemental Figure 2, right) was independently associated with improved clinical outcomes, after adjusting for age, sex, and tumor site. Here, CDK12 is linked to neoplasm.